Teladoc: Integrated Care + Real Free Cash Flow — A Trade to Catch the Turn
Teladoc is inexpensive on cash-flow metrics and is rolling out an outcomes-based integrated care product that can drive higher-margin revenue. With $193M in free cash flow and EV/EBITDA near 6x, the stock offers a payoff skew if execution on Teladoc One and BetterHelp stabilization occurs. This trade idea outlines an entry at $6.10, stop at $4.80 a…